Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice

Current Biology

Volumn 15, Issue 20, 2005, Pages 1839-1846

  Bayascas, Jose R ^a   Leslie, Nick R ^a   Parsons, Ramon ^b   Fleming, Stewart ^a   Alessi, Dario R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B KINASE; PROTEIN SERINE THREONINE KINASE; PTEN PROTEIN, MOUSE; S6 KINASE;

AGE; ANIMAL; ARTICLE; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MOUSE MUTANT; MUTATION; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL;

AGE FACTORS; ANIMALS; IMMUNOHISTOCHEMISTRY; MICE; MICE, MUTANT STRAINS; MUTATION; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PTEN PHOSPHOHYDROLASE; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

ANIMALIA;

EID: 27144480288     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2005.08.066     Document Type: Article

References (25)

1. B. Vanhaesebroeck, S.J. Leevers, K. Ahmadi, J. Timms, R. Katso, P.C. Driscoll, R. Woscholski, P.J. Parker, and M.D. Waterfield Synthesis and Function of 3-Phosphorylated Inositol Lipids Annu. Rev. Biochem. 70 2001 535 602
2. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
3. N.R. Leslie, and C.P. Downes PTEN function: how normal cells control it and tumour cells lose it Biochem. J. 382 2004 1 11
4. M.L. Sulis, and R. Parsons PTEN: from pathology to biology Trends Cell Biol. 13 2003 478 483
5. M.P. Myers, I. Pass, I.H. Batty, J. Van der Kaay, J.P. Stolarov, B.A. Hemmings, M.H. Wigler, C.P. Downes, and N.K. Tonks The lipid phosphatase activity of PTEN is critical for its tumor supressor function Proc. Natl. Acad. Sci. USA 95 1998 13513 13518
6. T. Maehama, and J.E. Dixon The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate J. Biol. Chem. 273 1998 13375 13378
7. V. Stambolic, A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Siderovski, and T.W. Mak Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1998 29 39
8. D. Haas-Kogan, N. Shalev, M. Wong, G. Mills, G. Yount, and D. Stokoe Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC Curr. Biol. 8 1998 1195 1198
9. A. Suzuki, J.L. de la Pompa, V. Stambolic, A.J. Elia, T. Sasaki, I. del Barco Barrantes, A. Ho, A. Wakeham, A. Itie, and W. Khoo High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice Curr. Biol. 8 1998 1169 1178
10. A. Di Cristofano, B. Pesce, C. Cordon-Cardo, and P.P. Pandolfi Pten is essential for embryonic development and tumour suppression Nat. Genet. 19 1998 348 355
11. K. Podsypanina, L.H. Ellenson, A. Nemes, J. Gu, M. Tamura, K.M. Yamada, C. Cordon-Cardo, G. Catoretti, P.E. Fisher, and R. Parsons Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proc. Natl. Acad. Sci. USA 96 1999 1563 1568
12. B. Stiles, V. Gilman, N. Khanzenzon, R. Lesche, A. Li, R. Qiao, X. Liu, and H. Wu Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis Mol. Cell. Biol. 22 2002 3842 3851
13. M.S. Neshat, I.K. Mellinghoff, C. Tran, B. Stiles, G. Thomas, R. Petersen, P. Frost, J.J. Gibbons, H. Wu, and C.L. Sawyers Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR Proc. Natl. Acad. Sci. USA 98 2001 10314 10319
14. A. Mora, D. Komander, D.M. Van Aalten, and D.R. Alessi PDK1, the master regulator of AGC kinase signal transduction Semin. Cell Dev. Biol. 15 2004 161 170
15. M.A. Lawlor, A. Mora, P.R. Ashby, M.R. Williams, V. Murray-Tait, L. Malone, A.R. Prescott, J.M. Lucocq, and D.R. Alessi Essential role of PDK1 in regulating cell size and development in mice EMBO J. 21 2002 3728 3738
16. L.C. Trotman, M. Niki, Z.A. Dotan, J.A. Koutcher, A. Di Cristofano, A. Xiao, A.S. Khoo, P. Roy-Burman, N.M. Greenberg, and T. Van Dyke Pten dose dictates cancer progression in the prostate PLoS Biol. 1 2003 e59 10.1371/journal.pbio.0000059
17. A. Di Cristofano, P. Kotsi, Y.F. Peng, C. Cordon-Cardo, K.B. Elkon, and P.P. Pandolfi Impaired Fas response and autoimmunity in Pten+/- mice Science 285 1999 2122 2125
18. D. Accili, and K.C. Arden FoxOs at the crossroads of cellular metabolism, differentiation, and transformation Cell 117 2004 421 426
19. A. Dufner, and G. Thomas Ribosomal S6 kinase signaling and the control of translation Exp. Cell Res. 253 1999 100 109
20. M. Constancia, M. Hemberger, J. Hughes, W. Dean, A. Ferguson-Smith, R. Fundele, F. Stewart, G. Kelsey, A. Fowden, and C. Sibley Placental-specific IGF-II is a major modulator of placental and fetal growth Nature 417 2002 945 948
21. R.I. Feldman, J.M. Wu, M.A. Polokoff, M.J. Kochanny, H. Dinter, D. Zhu, S.L. Biroc, B. Alicke, J. Bryant, and S. Yuan Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1 J. Biol. Chem. 280 2005 19867 19874
22. S. Sato, N. Fujita, and T. Tsuruo Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine) Oncogene 21 2002 1727 1738
23. D. Komander, G.S. Kular, J. Bain, M. Elliott, D.R. Alessi, and D.M. Van Aalten Structural basis for UCN-01 specificity and PDK1 inhibition Biochem. J. 375 2003 255 262
24. M. Raftopoulou, S. Etienne-Manneville, A. Self, S. Nicholls, and A. Hall Regulation of cell migration by the C2 domain of the tumor suppressor PTEN Science 303 2004 1179 1181
25. N.R. Leslie, D. Bennett, Y.E. Lindsay, H. Stewart, A. Gray, and C.P. Downes Redox regulation of PI 3-kinase signalling via inactivation of PTEN EMBO J. 22 2003 5501 5510